Metraipolis › archive › dc_df765bebacdf

Clinical Oncological Tolerance of Testosterone Replacement Therapy Over Two Years Among Patients With High-Risk or Very High-Risk Prostate Cancer Undergoing… — Europe PMC PMID:41127766

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41127766
DOI: 10.7759/cureus.92806
License (as archived): solo-consultazione
Archived: 2026-11-09T20:38:00.632Z
SHA-256 of the archived text: d05acec583cc27f457f8fd7cd2d066067cee1d967907c7d3d1c9fa8f1b18f975
Stable URL of this page: https://metraipolis.com/documento/dc_df765bebacdf

How to cite

Clinical Oncological Tolerance of Testosterone Replacement Therapy Over Two Years Among Patients With High-Risk or Very High-Risk Prostate Cancer Undergoing… — Europe PMC PMID:41127766 — Europe PMC (en), https://europepmc.org/article/MED/41127766 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df765bebacdf (Metraipolis archive dc_df765bebacdf, sha256 d05acec583cc27f457f8fd7cd2d066067cee1d967907c7d3d1c9fa8f1b18f975)

BibTeX

@misc{dcdf765bebacdf,
  title = {Clinical Oncological Tolerance of Testosterone Replacement Therapy Over Two Years Among Patients With High-Risk or Very High-Risk Prostate Cancer Undergoing… — Europe PMC PMID:41127766},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41127766},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df765bebacdf; sha256 d05acec583cc27f457f8fd7cd2d066067cee1d967907c7d3d1c9fa8f1b18f975},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41127766. Agents can read the archived copy with the MCP tool read_document.